$ALNY ALNYLAM PHARMACEUTICALS, INC. Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALNYLAM PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in ALNYLAM PHARMACEUTICALS, INC.. Find out how many shares they currently own, their value and whether they buy or sell their shares.
ALNYLAM PHARMACEUTICALS, INC. Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| Abingworth Management LTD | 10% Owner | 13,918 | 563,122 | Jan 20 2005 | |||
| Abingworth Management LTD | 10% Owner | 14,263 | 577,081 | Jan 12 2005 | |||
| Allen Patricia L | VP Finance and Treasurer | 0 | 0 | Dec 15 2006 | |||
| Allen Patricia L | VP of Finance and Treasurer | 7,260 | 293,740 | Dec 10 2010 | |||
| Allen Patricia L | VP of Finance/Treasurer | 0 | 0 | Apr 24 2009 | |||
| ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | 4,896,716 | 198,121,129 | Feb 24 2016 | |||
| ATLAS VENTURE FUND V LP | 10% Owner | 1,203,716 | 48,702,349 | Jun 07 2004 | |||
| ATLAS VENTURE FUND V LP | 10% Owner | 747,580 | 30,247,087 | Feb 27 2006 | |||
| Ausiello Dennis A | Director | 2,117 | 85,654 | Jul 06 2020 | |||
| Ausiello Dennis A | Director | 13,165 | 532,656 | Dec 10 2014 | |||
| Ausiello Dennis A | Director | 0 | 0 | Jun 10 2013 | |||
| Barrett Peter | Director | 2,340 | 94,676 | Jun 01 2004 | |||
| Barrett Peter | Director | 21,084 | 853,059 | Jun 02 2006 | |||
| Barrett Peter | Director | 13,095 | 529,824 | Feb 27 2006 | |||
| Berriman John E | Director | 2,475 | 100,139 | Jun 01 2004 | |||
| Berriman John E | Director | 0 | 0 | Jun 10 2005 | |||
| BONNEY MICHAEL W | Director | 4,000 | 161,840 | Jul 06 2020 | |||
| BRANDICOURT OLIVIER | Director | 0 | 0 | Mar 04 2020 | |||
| CHP II LP | 10% Owner | 232,500 | 9,406,950 | Jun 01 2004 | |||
| CLARKE JOHN K | Director | 23,891 | 966,630 | Jun 22 2018 | |||
| CLARKE JOHN K | Director | 0 | 0 | May 23 2014 | |||
| CLARKE JOHN K | Director | 2,091,868 | 84,636,979 | Jun 10 2005 | |||
| CLARKE JOHN K | Director | 0 | 0 | Jun 10 2013 | |||
| CLARKE JOHN K | Director | 0 | 0 | Jun 06 2014 | |||
| DZAU VICTOR J | Director | 0 | 0 | Jun 10 2013 | |||
| DZAU VICTOR J | Director | 0 | 0 | Jun 25 2012 | |||
| Fanucci Marsha | Director | 30,000 | 1,213,800 | Jul 06 2020 | |||
| Fanucci Marsha | Director | 0 | 0 | Jun 06 2014 | |||
| Fanucci Marsha | Director | 10,000 | 404,600 | Feb 23 2012 | |||
| Fanucci Marsha | Director | 0 | 0 | Jun 10 2013 | |||
| Greene Barry E | President | 65,412 | 2,646,570 | Sep 11 2020 | |||
| Greene Barry E | President and COO | 4,572 | 184,983 | Dec 16 2014 | |||
| Greene Barry E | President and COO | 23,392 | 946,440 | Dec 22 2014 | |||
| Greenstreet Yvonne | President & COO | 13,374 | 541,112 | Apr 21 2021 | |||
| Gros David-Alexandre C | SVP, Chief Business Officer | 1,000 | 40,460 | Dec 22 2016 | |||
| HAMBURG MARGARET A | Director | 0 | 0 | Jul 06 2020 | |||
| KEATING LAURIE | EVP, Chief Legal Officer | 8,955 | 362,319 | Apr 21 2021 | |||
| KOBLAN KENNETH S | Chief Scientific Officer | 0 | 0 | Dec 10 2010 | |||
| MARAGANORE JOHN | Chief Executive Officer | 248,744 | 10,064,182 | May 17 2021 | |||
| MARAGANORE JOHN | President & CEO | 5,135 | 207,762 | May 16 2006 | |||
| MARAGANORE JOHN | CEO | 106,320 | 4,301,707 | Apr 15 2014 | |||
| MARAGANORE JOHN | CEO | 0 | 0 | Jun 18 2009 | |||
| MARAGANORE JOHN | CEO | 50,000 | 2,023,000 | Aug 18 2010 | |||
| MARAGANORE JOHN | CEO | 58,503 | 2,367,031 | Feb 23 2012 | |||
| Mason Michael | VP, Finance and Treasurer | 1,012 | 40,946 | Sep 28 2018 | |||
| Mason Michael | VP, Finance and Tresurer | 5,287 | 213,912 | Jan 27 2014 | |||
| Mason Michael | VP, Finance and Treasurer | 0 | 0 | Dec 16 2014 | |||
| Miles Vincent J | Senior VP Business Development | 0 | 0 | Dec 09 2005 | |||
| NOVARTIS AG | 10% Owner | 5,602,898 | 226,693,253 | Apr 26 2010 | |||
| NOVARTIS AG | 10% Owner | 4,051,002 | 163,903,541 | Sep 24 2012 | |||
| NOVARTIS AG | 10% Owner | 5,481,753 | 221,791,726 | May 14 2008 | |||
| PAUL STEVEN M | Director | 16,000 | 647,360 | Dec 22 2020 | |||
| PAUL STEVEN M | Director | 0 | 0 | Jun 10 2013 | |||
| PAUL STEVEN M | Director | 1,000 | 40,460 | Jan 28 2015 | |||
| POLARIS VENTURE MANAGEMENT CO III LLC | 10% Owner | 37,074 | 1,500,014 | Feb 24 2005 | |||
| Poulton Jeffrey V. | Chief Financial Officer | 4,518 | 182,798 | Apr 21 2021 | |||
| PYOTT DAVID E I | Director | 27,900 | 1,128,834 | Jul 06 2020 | |||
| Reid Laurence | SVP, Chief Business Officer | 3,905 | 157,996 | Dec 16 2014 | |||
| Reid Laurence | SVP, Chief Business Officer | 18,103 | 732,447 | Jan 05 2015 | |||
| Reitan Colleen F | Director | 0 | 0 | Jul 06 2020 | |||
| Sanofi | 10% Owner | 10,051,603 | 406,687,857 | Feb 02 2015 | |||
| SANOFI-AVENTIS | 10% Owner | 10,554,134 | 427,020,262 | Jun 01 2017 | |||
| SATO VICKI L | Director | 0 | 0 | Dec 09 2005 | |||
| SATO VICKI L | Director | 0 | 0 | Jun 04 2010 | |||
| SCHIMMEL PAUL | Director | 10,000 | 404,600 | Jul 02 2019 | |||
| SCHIMMEL PAUL | Director | 252,111 | 10,200,411 | Feb 23 2012 | |||
| SCHIMMEL PAUL | Director | 126,216 | 5,106,699 | Oct 24 2013 | |||
| SCHIMMEL PAUL | Director | 0 | 0 | Dec 10 2014 | |||
| Schmidt John A Jr | SVP, Chief Scientific Officer | 0 | 0 | Dec 11 2008 | |||
| SCHULMAN AMY W | Director | 0 | 0 | Jul 06 2020 | |||
| SCOLNICK EDWARD M | Director | 0 | 0 | Jun 12 2009 | |||
| SHARP PHILIP A | Director | 0 | 0 | Dec 22 2020 | |||
| SHARP PHILIP A | Director | 264,912 | 10,718,340 | Jun 10 2013 | |||
| SHARP PHILIP A | Director | 0 | 0 | Sep 14 2006 | |||
| SHARP PHILIP A | Director | 191,903 | 7,764,395 | Oct 15 2014 | |||
| SHARP PHILIP A | Director | 9,302 | 376,359 | Feb 23 2012 | |||
| Soni Manmeet Singh | Chief Financial Officer | 2 | 81 | Mar 01 2019 | |||
| STARR KEVIN P | Director | 0 | 0 | Jun 06 2017 | |||
| STARR KEVIN P | Director | 0 | 0 | Jun 02 2006 | |||
| STARR KEVIN P | Director | 0 | 0 | Jun 06 2014 | |||
| STARR KEVIN P | Director | 0 | 0 | Mar 26 2013 | |||
| Vaishnaw Akshay | President, R&D | 22,908 | 926,858 | Apr 21 2021 | |||
| Vaishnaw Akshay | EVP, Chief Medical Officer | 0 | 0 | Sep 17 2014 | |||
| Vaishnaw Akshay | EVP, Chief Medical Officer | 12,588 | 509,310 | Sep 12 2013 | |||
| Vaishnaw Akshay | EVP, Chief Medical Officer | 0 | 0 | Dec 16 2014 | |||
| VINCENT JAMES L | Director | 10,000 | 404,600 | Jun 02 2006 | |||
| VINCENT JAMES L | Director | 0 | 0 | Jun 18 2010 | |||
| Westphal Christoph H | Director | 300,170 | 12,144,878 | Jun 01 2004 | |||
| Westphal Christoph H | Director | 2,409,970 | 97,507,386 | Jun 07 2004 |